Intuitive Surgical faces shareholder class action lawsuit

legal gavel illustration

Shareholders of Intuitive Surgical (NSDQ:ISRG) late last month filed a class action lawsuit accusing the robot-assisted surgery giant and its executives of artificially inflating the company’s stock price with misleading statements and "disreputable" sales practices.

The lawsuit claims that Intuitive and a 9 of it executives concealed safety and efficacy problems with the da Vinci surgical system while posting "quarter after quarter of record financial results," a scheme that the plaintiffs say allowed company leadership to cash in on their personally held stock at "fraud-inflated" prices worth hundreds of millions.

"The da Vinci robot is the subject of a growing number of personal injury lawsuits, while at the same time, regulatory scrutiny of the device has also increased," according to the law firm of Bernstein Liebhard LLP, which is not involved in the shareholder suit but is offering services to patients who believe they suffered injuries as a result of treatment with the da Vinci system. "It’s not surprising that these developments have sparked shareholder concerns."

The shareholder lawsuit claims that Intuitive knew or "recklessly disregarded" and concealed from the public information relating to adverse events associated with use of the da Vinci system and possible FDA restrictions on sales of the device, and that the company failed to properly set aside funds to cover potential liabilities in patient lawsuits.

"Due in large part to what the public has recently learned were disreputable and unsafe practices, the number of U.S. procedures done with the robots grew to approximately 367,000 in 2012, up from 292,000 in 2011 and 228,000 in 2010," the lawsuit claims. "Meanwhile, the price of Intuitive stock soaring, nearly every senior executive of Intuitive cashed in, collectively selling close to 410,000 shares of their personally held Intuitive stock into the open market at fraud-inflated prices during the Class Period, reaping more than $218.6 million in proceeds."

Intuitive has been the target of a lot of bad press recently, including patient injury lawsuits, an FDA probe of adverse events and warnings of possible fractures on certain of its devices.

The device maker recently won the 1st lawsuit to go to trial when a jury ruled 10-2 that the company was not liable in the death of Fred Taylor or responsible for any damages to his family. The company isn’t out of the woods yet – that was the 1st of at least 26 different lawsuits filed across the country involving the company’s da Vinci robotic surgery device.

ISRG shares were modestly down 0.1% to $496.97 as of about 10:45 a.m. today.

RSS From Medical Design & Outsourcing

  • Teknor Apex to showcase wide range of PVC compounds for medical devices at Medtec China
    Building on its international leadership role as a supplier of medical-grade PVC compounds, Teknor Apex Company has developed flexible and rigid formulations that address the special needs of device manufacturers. The company will highlight these capabilities at Medtec China 2015. “Teknor Apex produces or markets medical-grade PVC compounds in China, Singapore, Europe, and the United […]
  • The Raspberry Pi eco-system goes interstellar with the new Raspberry Pi Sense HAT
    Newark element14 has globally launched the latest addition to the expanding ecosystem of Raspberry Pi accessories, the Raspberry Pi Sense HAT, as featured in the ‘Astro Pi’ space mission. The Sense HAT will enable enthusiasts to control the same hardware used in space. The Sense HAT attaches to the Raspberry Pi board, and can be […]
  • CommScope completes acquisition of TE Connectivity’s Telecom
    CommScope Holding Company, has completed its previously announced acquisition of TE Connectivity’s Telecom, Enterprise and Wireless businesses, a leader in fiber optic connectivity for wireline and wireless networks. The all-cash transaction, valued at approximately $3 billion, strengthens CommScope’s position as a leading communications infrastructure provider with deeper resources to meet the world’s growing demand for network […]
  • SPI awards IKO Prosthetic Creative System the Student Design International Design Excellence Award
    SPI: The Plastics Industry Trade Association congratulated IKO Prosthetic Creative System for winning the SPI Student Design Award, part of the Industrial Designers Society of America’s (IDSA’s) International Design Excellence Awards (IDEA) program. The award was presented to IKO, an innovative, youth-focused prosthetic design company led by Chicago-based designer Carlos Torres, by SPI’s Senior Director of […]
  • New assay could revolutionize diagnosis and treatment of life-threatening disease
    Invasive Fungal Disease (IFD) is an emerging global health problem associated with high mortality rates in severely immunocompromised patients, such as those undergoing intensive chemotherapy or stem cell transplantation, and in patients suffering immune compromising conditions such as AIDS. The most common causative agents of this disease have been identified as Candida and Aspergillus species, […]
  • Molex delivers ISO 13485-compliant, medical-grade surgical cables from its class 100,000 clean room facility
    Molex, LLC operates a fully ISO 146441-1:1999 Class 8-certified clean room, satisfying strict particulate contamination levels specified by ISO-compliant requirements. Located in Thailand, the facility has less than 100,000 particulates (≥0.5µm) per cubic foot of air and manufactures a variety of ISO 13485-compliant medical cables and surgical cables used in operating theatres, hospitals, laboratories and […]
  • Swept-Source OCT: Patent license agreement between Massachusetts General Hospital and Heidelberg Engineering
    Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and […]
  • MIT’s MultiFab presents a stark challenge to incumbent 3D Printer manufacturers’ hardware, software, and business Models
    MIT’s Computational Fabrication Group recently announced the MultiFab, a low-cost 3D printer that can combine up to 10 different resins in one part and also includes a 3D scanning system to identify and fix errors during production. According to Lux Research, these capabilities are rare in commercial 3D printers today due to the manufacturers’ need […]
  • AVX releases Accu-P MP medical grade film chip capacitors for medical devices
    AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released a new series of thin film chip capacitors specifically designed to meet the demanding performance specifications for implantable medical devices. Delivering extremely tight capacitive tolerances, exceptionally repeatable performance, and remarkably low ESR and high Q at high frequencies—including VHF, UHF, and RF […]
  • RIVANNA commences manufacturing of its Accuro device
    Rivanna Medical announced that it has begun manufacturing its FDA-cleared Accuro device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San […]
  • FDA seeks public input on Quality Metrics guidance
    by Oliver Wolf, Senior Product Manager, MasterControl In line with the general shift towards risk-driven approaches in the quality management world, FDA is now taking steps towards applying those same principles to its own auditing schedule. At the end of July, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation […]

Leave a Reply